Asokan is usually among four fresh investigators to get the awards this season for his or her significant contributions to the field of gene therapy. His laboratory in the UNC Gene Therapy Center combines the various tools and concepts of molecular biology and genetics with chemistry to generate a ‘artificial viral toolkit.’ The resulting designed viral strains are accustomed to unravel viral infectious pathways, produce novel vectors for gene therapy and reagents for molecular genetics applications. Related StoriesNew interactive device helps researchers explore genetic underpinnings of cancerGenetics and race influence sufferers' response to anticancer medication treatmentsRUCDR Infinite Biologics awarded $6 million grant from NINDS During the ASGCT 16th Annual Meeting in Salt Lake City, Utah, this year'on Saturday May 18th s award winners will show summaries of their just work at the Outstanding New Investigator Symposium..Elly Katabira, International Chair of AIDS 2012 and President of the International AIDS Society . ‘The results of the CAPRISA trial shown at AIDS 2010 and the info from IAS 2011 proving beyond any doubt that treatment is definitely prevention have shown us there are the true potential to improve the direction of HIV. Science has offered us with the tools, what we need now could be a worldwide political and economic dedication to action. A turbulent financial state must not halt funding for research and implementation’. The return of the International AIDS Conference to the United States after more than twenty years represents a triumph for public health and human rights and it is the result of dedicated advocacy to get rid of the country’s misguided entry limitations on people coping with HIV.